Skip to main content
uniQure N.V. logo

uniQure N.V. — Investor Relations & Filings

Ticker · QURE ISIN · NL0010696654 LEI · 724500RPCTZLFYJZ3S98 US Manufacturing
Open in API
Filings indexed 859 across all filing types
Latest filing 2020-06-23 Director's Dealing
Country NL Netherlands
Listing US QURE

About uniQure N.V.

https://www.uniqure.com/

uniQure N.V. is a gene therapy company focused on developing and commercializing treatments for patients with rare and severe diseases. The company utilizes its adeno-associated virus (AAV) based technology platform to create single-administration therapies with the potential for curative results. Its research and development pipeline is concentrated on liver-directed and central nervous system (CNS) disorders, with a key clinical program targeting Huntington's disease. uniQure aims to deliver transformative medicines by translating scientific innovation into viable treatments.

Recent filings

Filing Released Lang Actions
3
Director's Dealing
2020-06-23 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated June 17, 2020, by uniQure N.V. The content focuses on the submission of matters to a vote of security holders at the 2020 Annual General Meeting (AGM). It details the voting results on various agenda items such as adoption of annual accounts, discharge of board liability, reappointments and appointments of directors, renewal of board authorities, and approval of compensation. The document is not the full annual report or proxy statement but specifically reports the official voting results from the AGM. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length (8106 characters) and detailed vote counts further support this classification rather than a brief announcement or proxy solicitation. Therefore, the filing type is DVA with high confidence.
2020-06-22 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text indicates it is a short filing (3442 characters) announcing a press release about the first two patients treated in a clinical study. It includes no financial statements or detailed financial data. The document is primarily an announcement of an event and includes a press release as an exhibit. It does not contain quarterly or annual financial results, management discussion, or audit information. Therefore, it is not an Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or any detailed financial report. It is also not a regulatory certification or officer attestation. Given the nature of the filing and its length, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other categories.
2020-06-22 English
PRIMARY DOCUMENT
Director's Dealing
2020-06-22 English
DEF 14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, specifically a Definitive Additional Materials supplement to a Proxy Statement related to the Annual General Meeting (AGM) of shareholders. It announces a change in the location and format of the 2020 AGM to a virtual meeting due to COVID-19. It references the original proxy statement filed on April 29, 2020, and provides instructions for shareholders to participate and vote. The document does not contain the proxy statement itself, nor does it include voting results or detailed AGM materials. It is an announcement related to the AGM process and proxy materials, not the AGM presentation or voting results. Therefore, it fits best under Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings, including supplements and amendments to proxy statements.
2020-06-15 English
PRIMARY DOCUMENT
Director's Dealing
2020-05-22 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.